Cargando…

Anaphylactic response to topical fluorescein 2% eye drops: a case report

INTRODUCTION: The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Humma, Salmon, John F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837668/
https://www.ncbi.nlm.nih.gov/pubmed/20181047
http://dx.doi.org/10.1186/1752-1947-4-27
_version_ 1782178842828341248
author Shahid, Humma
Salmon, John F
author_facet Shahid, Humma
Salmon, John F
author_sort Shahid, Humma
collection PubMed
description INTRODUCTION: The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions. CASE PRESENTATION: We report the case of a 51-year-old woman who developed an anaphylactic reaction when she was administered fluorescein sodium 2% eye drops after cataract surgery. This was the second time she had been exposed to fluorescein. She had brittle asthma and a history of anaphylaxis following exposure to a variety of drug and food allergens. She was successfully resuscitated and recovered completely over a period of two days. CONCLUSIONS: Fluorescein 2% drops are universally used in general practice, ophthalmology, optometry, and casualty departments. Our case report reveals the potential for this benign eye drop to cause a life-threatening systemic reaction and emphasises the importance of considering this consequence when administering topical fluorescein 2% to a patient with a history of anaphylaxis to other allergens.
format Text
id pubmed-2837668
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28376682010-03-13 Anaphylactic response to topical fluorescein 2% eye drops: a case report Shahid, Humma Salmon, John F J Med Case Reports Case report INTRODUCTION: The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions. CASE PRESENTATION: We report the case of a 51-year-old woman who developed an anaphylactic reaction when she was administered fluorescein sodium 2% eye drops after cataract surgery. This was the second time she had been exposed to fluorescein. She had brittle asthma and a history of anaphylaxis following exposure to a variety of drug and food allergens. She was successfully resuscitated and recovered completely over a period of two days. CONCLUSIONS: Fluorescein 2% drops are universally used in general practice, ophthalmology, optometry, and casualty departments. Our case report reveals the potential for this benign eye drop to cause a life-threatening systemic reaction and emphasises the importance of considering this consequence when administering topical fluorescein 2% to a patient with a history of anaphylaxis to other allergens. BioMed Central 2010-01-29 /pmc/articles/PMC2837668/ /pubmed/20181047 http://dx.doi.org/10.1186/1752-1947-4-27 Text en Copyright ©2010 Shahid and Salmon; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case report
Shahid, Humma
Salmon, John F
Anaphylactic response to topical fluorescein 2% eye drops: a case report
title Anaphylactic response to topical fluorescein 2% eye drops: a case report
title_full Anaphylactic response to topical fluorescein 2% eye drops: a case report
title_fullStr Anaphylactic response to topical fluorescein 2% eye drops: a case report
title_full_unstemmed Anaphylactic response to topical fluorescein 2% eye drops: a case report
title_short Anaphylactic response to topical fluorescein 2% eye drops: a case report
title_sort anaphylactic response to topical fluorescein 2% eye drops: a case report
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837668/
https://www.ncbi.nlm.nih.gov/pubmed/20181047
http://dx.doi.org/10.1186/1752-1947-4-27
work_keys_str_mv AT shahidhumma anaphylacticresponsetotopicalfluorescein2eyedropsacasereport
AT salmonjohnf anaphylacticresponsetotopicalfluorescein2eyedropsacasereport